ImadShureiqiMD

Oncology • Ann Arbor, MI

Physician

Join to view full profile

Dr. Shureiqi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shureiqi's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 1994 - 1997
University at BuffaloFellowship, Hematology and Medical Oncology, 1991 - 1992
University at BuffaloResidency, Internal Medicine, 1989 - 1991
Damascus University Faculty of MedicineClass of 1985

Certifications & Licensure

TX State Medical License 1999 - 2026
MI State Medical License 1990 - 2025
OK State Medical License 2020 - 2021
WV State Medical License 1992 - 1995
American Board of Internal Medicine Medical Oncology

Clinical Trials

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers Start of enrollment: 2003 Aug 20
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Dysregulated KLF4 expression plays a pivotal role in the pathogenesis of pancreatic intraductal papillary mucinous neoplasms.
Xiangsheng Zuo, Liang Wang, Yi Liu, Huamin Wang, Margarete Hafley
Gut. 2025-01-17
3 citations
EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms.
Yoshiyuki Kiyasu, Xiangsheng Zuo, Yi Liu, James C Yao, Imad Shureiqi
Prostaglandins & Other Lipid Mediators. 2024-10-01
9 citations
PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Yi Liu, Daoyan Wei, Yasunori Deguchi, Weiguo Xu, Rui Tian
Gastric Cancer. 2023-11-01

Press Mentions

Science Reveals That This Type of Diet Can Increase Your Risk of Pancreatic CancerJuly 30th, 2022
Colorectal Cancer Survivor Turns to Clinical Trial for Neuropathy ReliefOctober 30th, 2018
Throat Cancer Survivor Now Singing MD Anderson’s PraisesSeptember 25th, 2017

Grant Support

PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolismUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolismUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026